Researchers evaluated the impact of CHIP and pre-treatment neutropenia on outcomes in patients receiving CAR T-cell therapy.

Adding intismeran to pembrolizumab linked to reduced risk for recurrence, death for surgically resected melanoma.

Divarasib led to significantly longer progression-free and overall survival compared with control treatment.

Researchers evaluated whether malnutrition independently increases the risk of chemotherapy-induced cardiovascular toxicity in patients with colorectal cancer.

Persistent pancytopenia following gynecologic cancer treatment warrants evaluation for t-MDS, a secondary malignancy associated with poor outcomes.

Researchers explored oncology nurses' perspectives on administering home-based parenteral antineoplastic therapy, focused on implementation barriers and facilitators.

Researchers evaluated cases of immune checkpoint inhibitor-induced autoimmune hemolytic anemia to better understand its clinical characteristics, timing, and treatment management.

Researchers evaluated the effect of selective estrogen receptor modulators on lipid metabolism and fatty liver disease risk in women with breast cancer.

Explore sessions from JADPRO Live 2026 on non-small cell lung cancer, including next-generation sequencing, adverse effect management, and oligometastatic disease evaluation.

Remission after bridging therapy and at 1 month after infusion was associated with improved survival, supporting early response assessment.

A systematic review and meta-analysis evaluated the effectiveness and patient satisfaction of virtual reality interventions for anxiety management in individuals with cancer.

Investigators assessed the relationship between distinct symptom clusters and quality of life in patients who underwent thyroid cancer surgery.